{"id":"https://openalex.org/A5073796708","orcid":"https://orcid.org/0000-0002-2271-6240","observed_orcids":["https://orcid.org/0000-0002-2271-6240"],"display_name":"Dirk A. Bornemeier","raw_author_names":["Dirk A. Bornemeier","Dirk Bornemeier"],"full_name":"Dirk A. Bornemeier","works_count":15,"cited_by_count":899,"summary_stats":{"2yr_mean_citedness":0.0,"h_index":10,"i10_index":10},"ids":{"openalex":"https://openalex.org/A5073796708","orcid":"https://orcid.org/0000-0002-2271-6240","observed_orcids":["https://orcid.org/0000-0002-2271-6240"]},"affiliations":[{"institution":{"id":"https://openalex.org/I165733156","ror":"https://ror.org/00te3t702","display_name":"University of Georgia","country_code":"US","type":"education","lineage":["https://openalex.org/I165733156"]},"years":[2007]},{"institution":{"id":"https://openalex.org/I180857899","ror":"https://ror.org/01xdqrp08","display_name":"Pfizer (United States)","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},"years":[2008,2007]},{"institution":{"id":"https://openalex.org/I27837315","ror":"https://ror.org/00jmfr291","display_name":"University of Michigan","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]},"years":[2007]},{"institution":{"id":"https://openalex.org/I4210088555","ror":"https://ror.org/0052svj16","display_name":"Abbott (United States)","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088555"]},"years":[1985]}],"last_known_institutions":null,"topics":[{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","count":9,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","count":8,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","count":4,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12410","display_name":"Structural and Chemical Analysis of Organic and Inorganic Compounds","count":4,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12910","display_name":"Eicosanoids and Hypertension Pharmacology","count":4,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"topic_share":[{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","value":3.95e-05,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12910","display_name":"Eicosanoids and Hypertension Pharmacology","value":3.26e-05,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","value":2.24e-05,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12412","display_name":"Enzyme function and inhibition","value":1.86e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12410","display_name":"Structural and Chemical Analysis of Organic and Inorganic Compounds","value":1.7e-05,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"x_concepts":[{"id":"185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","score":0.9489641189575195},{"id":"181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","score":0.7204456329345703},{"id":"55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","score":0.6452449560165405},{"id":"71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","score":0.596160888671875},{"id":"71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","score":0.3911151885986328}],"counts_by_year":[{"year":1985,"works_count":1,"oa_works_count":0,"cited_by_count":0},{"year":1992,"works_count":2,"oa_works_count":0,"cited_by_count":0},{"year":1993,"works_count":2,"oa_works_count":0,"cited_by_count":0},{"year":1995,"works_count":1,"oa_works_count":0,"cited_by_count":0},{"year":1996,"works_count":1,"oa_works_count":0,"cited_by_count":0},{"year":1999,"works_count":3,"oa_works_count":1,"cited_by_count":0},{"year":2007,"works_count":3,"oa_works_count":1,"cited_by_count":0},{"year":2008,"works_count":1,"oa_works_count":1,"cited_by_count":0},{"year":2012,"works_count":0,"oa_works_count":0,"cited_by_count":67},{"year":2013,"works_count":0,"oa_works_count":0,"cited_by_count":61},{"year":2014,"works_count":0,"oa_works_count":0,"cited_by_count":48},{"year":2015,"works_count":0,"oa_works_count":0,"cited_by_count":54},{"year":2016,"works_count":0,"oa_works_count":0,"cited_by_count":31},{"year":2017,"works_count":1,"oa_works_count":1,"cited_by_count":33},{"year":2018,"works_count":0,"oa_works_count":0,"cited_by_count":31},{"year":2019,"works_count":0,"oa_works_count":0,"cited_by_count":23},{"year":2020,"works_count":0,"oa_works_count":0,"cited_by_count":29},{"year":2021,"works_count":0,"oa_works_count":0,"cited_by_count":28},{"year":2022,"works_count":0,"oa_works_count":0,"cited_by_count":18},{"year":2023,"works_count":0,"oa_works_count":0,"cited_by_count":19},{"year":2024,"works_count":0,"oa_works_count":0,"cited_by_count":25},{"year":2025,"works_count":0,"oa_works_count":0,"cited_by_count":28},{"year":2026,"works_count":0,"oa_works_count":0,"cited_by_count":9}],"display_name_alternatives":["Dirk A. Bornemeier","Dirk Bornemeier"],"block_key":"d bornemeier","works_api_url":"https://api.openalex.org/works?filter=author.id:A5073796708","updated_date":"2026-11-07T12:08:38","created_date":"2016-06-24T00:00:00"}